Compedica is a medical device company on a mission to transform how diabetic foot ulcers (DFUs) are treated, operating in the UK and the UAE. The company has developed PulseFlowDF, an FDA and CE-approved wearable therapy system that combines mobile offloading, blood flow stimulation, and compliance monitoring into a single, user-friendly device.

DFUs are one of the most debilitating and costly complications of diabetes, often leading to infection and amputation. With over 425 million people globally living with diabetes, and 34% facing a lifetime risk of developing a DFU, the clinical and economic burden is massive. Compedica’s innovation addresses this by enabling patients to heal at home without sacrificing mobility, offering a solution that is clinically effective and cost effective for health systems.

Visit Compedica’s Website